Chargement en cours...

The Risks of miRNA Therapeutics: In a Drug Target Perspective

RNAi therapeutics have been growing. Patisiran and givosiran, two siRNA-based drugs, were approved by the Food and Drug Administration in 2018 and 2019, respectively. However, there is rare news on the advance of miRNA drugs (another therapeutic similar to siRNA drug). Here we report the existing ob...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Drug Des Devel Ther
Auteurs principaux: Zhang, Song, Cheng, Zhujun, Wang, Yanan, Han, Tianyu
Format: Artigo
Langue:Inglês
Publié: Dove 2021
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7910153/
https://ncbi.nlm.nih.gov/pubmed/33654378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S288859
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!